1. Home
  2. SCLX vs LPA Comparison

SCLX vs LPA Comparison

Compare SCLX & LPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$19.15

Market Cap

139.3M

Sector

Health Care

ML Signal

HOLD

LPA

Logistic Properties of the Americas

HOLD

Current Price

$3.00

Market Cap

155.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
LPA
Founded
2011
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
139.3M
155.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SCLX
LPA
Price
$19.15
$3.00
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
122.8K
32.6K
Earning Date
11-14-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.21
Revenue
$40,360,000.00
$47,536,343.00
Revenue This Year
N/A
N/A
Revenue Next Year
$749.70
N/A
P/E Ratio
N/A
$14.19
Revenue Growth
N/A
7.28
52 Week Low
$3.60
$2.55
52 Week High
$34.27
$11.47

Technical Indicators

Market Signals
Indicator
SCLX
LPA
Relative Strength Index (RSI) 51.13 38.89
Support Level $18.34 $3.05
Resistance Level $20.62 $3.60
Average True Range (ATR) 2.22 0.20
MACD -0.02 0.02
Stochastic Oscillator 32.91 1.69

Price Performance

Historical Comparison
SCLX
LPA

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About LPA Logistic Properties of the Americas

Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns, and manages a diversified portfolio of warehouse logistics assets in Central America and South America. It focuses on modern Class A logistics real estate in high-growth and high-barrier-to-entry markets that are undersupplied and have low penetration rates. The company has three operating segments, based on geographic regions, consisting of Colombia, Peru, and Costa Rica. The company generates the majority of its revenue from the Costa Rica geographical segment.

Share on Social Networks: